JPH11512442A5 - - Google Patents

Info

Publication number
JPH11512442A5
JPH11512442A5 JP1997512335A JP51233597A JPH11512442A5 JP H11512442 A5 JPH11512442 A5 JP H11512442A5 JP 1997512335 A JP1997512335 A JP 1997512335A JP 51233597 A JP51233597 A JP 51233597A JP H11512442 A5 JPH11512442 A5 JP H11512442A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997512335A
Other languages
English (en)
Japanese (ja)
Other versions
JP4824147B2 (ja
JPH11512442A (ja
Filing date
Publication date
Priority claimed from GBGB9519197.9A external-priority patent/GB9519197D0/en
Application filed filed Critical
Publication of JPH11512442A publication Critical patent/JPH11512442A/ja
Publication of JPH11512442A5 publication Critical patent/JPH11512442A5/ja
Application granted granted Critical
Publication of JP4824147B2 publication Critical patent/JP4824147B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP51233597A 1995-09-20 1996-09-19 新規な親和性リガンド類およびそれらの用途 Expired - Lifetime JP4824147B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9519197.9 1995-09-20
GBGB9519197.9A GB9519197D0 (en) 1995-09-20 1995-09-20 Novel affinity ligands and their use
PCT/DK1996/000399 WO1997010887A1 (en) 1995-09-20 1996-09-19 Novel affinity ligands and their use

Publications (3)

Publication Number Publication Date
JPH11512442A JPH11512442A (ja) 1999-10-26
JPH11512442A5 true JPH11512442A5 (https=) 2004-09-30
JP4824147B2 JP4824147B2 (ja) 2011-11-30

Family

ID=10780990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51233597A Expired - Lifetime JP4824147B2 (ja) 1995-09-20 1996-09-19 新規な親和性リガンド類およびそれらの用途

Country Status (16)

Country Link
EP (1) EP0959975B1 (https=)
JP (1) JP4824147B2 (https=)
KR (1) KR100537386B1 (https=)
CN (1) CN1089617C (https=)
AR (1) AR003634A1 (https=)
AT (1) ATE285827T1 (https=)
AU (1) AU702901B2 (https=)
CA (1) CA2232626C (https=)
DE (1) DE69634142T2 (https=)
DK (1) DK0959975T3 (https=)
ES (1) ES2236748T3 (https=)
GB (1) GB9519197D0 (https=)
MY (1) MY127957A (https=)
RU (1) RU2175261C2 (https=)
WO (1) WO1997010887A1 (https=)
ZA (1) ZA967917B (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760187A (en) * 1996-02-22 1998-06-02 Mitsui Toatsu Chemicals, Inc. Purification process of a human growth hormone
ATE441476T1 (de) * 1996-08-30 2009-09-15 Upfront Chromatography As Isolierung von immunoglobulinen
EP0945447A1 (en) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
GB9910807D0 (en) 1999-05-10 1999-07-07 Prometic Biosciences Limited Novel detoxification agents and their use
CA2384188C (en) 1999-09-24 2008-06-17 Janssen Pharmaceutica N.V. Antiviral compositions
US6153364A (en) * 1999-12-16 2000-11-28 Eastman Kodak Company Photographic processing methods using compositions containing stain reducing agent
US6153365A (en) 1999-12-16 2000-11-28 Eastman Kodak Company Photographic processing compositions containing stain reducing agent
WO2001083515A2 (en) * 2000-04-28 2001-11-08 Accurate Polymers, Inc. Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
US6288227B1 (en) 2000-10-05 2001-09-11 Eastman Kodak Company Solublized 2,6-dinaphthylaminotriazines
US6440651B1 (en) 2000-10-05 2002-08-27 Eastman Kodak Company Concentrated photographic fixer additive and fixing compositions and method of photographic processing
WO2002072561A1 (en) * 2001-01-26 2002-09-19 Smithkline Beecham Corporation Piperazinyltriazines as estrogen receptor modulators
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
GB0224446D0 (en) * 2002-10-21 2002-11-27 Univ Cambridge Tech Affinity adsorbents for immunoglobulins
GB0228724D0 (en) 2002-12-09 2003-01-15 Prometic Biosciences Ltd Multidimensinal libraries
US7109040B2 (en) * 2002-12-13 2006-09-19 Agilent Technologies, Inc. Modular isotope coding approach to proteomic analysis
US7700743B2 (en) * 2003-07-22 2010-04-20 Millipore Corporation Immobilised affinity medium and its use in separation
SE0400501D0 (sv) * 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
AU2005216847B2 (en) * 2004-02-27 2010-04-01 Cytiva Bioprocess R&D Ab A process for the purification of antibodies
SE0401665D0 (sv) * 2004-06-24 2004-06-24 Amersham Biosciences Ab Purification of immunoglobulins
GB0416699D0 (en) * 2004-07-27 2004-09-01 Prometic Biosciences Ltd Prion protein ligands and methods of use
WO2006024175A1 (en) * 2004-09-03 2006-03-09 Prometic Biosciences Inc. 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE
KR101243601B1 (ko) * 2004-10-21 2013-03-20 지이 헬스케어 바이오-사이언시스 에이비 크로마토그래피 리간드
ES2395544T3 (es) 2004-12-23 2013-02-13 Novo Nordisk Health Care Ag Reducción del contenido de contaminantes proteínicos en composiciones que comprenden una proteína dependiente de la vitamina K de interés
US20080311681A1 (en) * 2004-12-23 2008-12-18 Ib Johannsen Antibody Binding Affinity Ligands
GB0509443D0 (en) * 2005-05-09 2005-06-15 Prometic Biosciences Ltd Affinity adsorbents for factor VIII and von willebrand's factor
GB0509442D0 (en) * 2005-05-09 2005-06-15 Prometic Biosciences Ltd Affinity adsorbents for fibrinogen
GB0509438D0 (en) * 2005-05-09 2005-06-15 Prometic Biosciences Ltd Affinity adsorbets for fibrinogen
WO2006131768A2 (en) * 2005-06-10 2006-12-14 Prometic Biosciences Limited Triazines as protein binding ligands
US20080220968A1 (en) * 2005-07-05 2008-09-11 Ge Healthcare Bio-Sciences Ab [1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg
GB0604236D0 (en) * 2006-03-02 2006-04-12 Prometic Biosciences Ltd Adsorbents for protein purification
JP5888481B2 (ja) 2007-03-28 2016-03-22 ディーピーエックス ホールディングス ビー.ブイ. 膨張床カラムおよび使い捨て可能なクロマトグラフィー
JP5450381B2 (ja) * 2007-04-30 2014-03-26 プロメティック・バイオサイエンスィズ・インコーポレーテッド 化合物、そのような化合物を含有する組成物、及びそのような化合物を用いるがん及び自己免疫疾患の治療法
GB0808908D0 (en) * 2008-05-16 2008-06-25 Avecia Biolog Ltd Purification process
PT2300013T (pt) 2008-05-21 2017-10-31 Ariad Pharma Inc Derivados de fósforo como inibidores de cinases
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
WO2010055135A1 (en) * 2008-11-13 2010-05-20 Novo Nordisk A/S Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands
HRP20192259T1 (hr) 2009-04-15 2020-03-06 Abraxis Bioscience, Llc Pripravci nanočestica bez priona i metode njihove proizvodnje
DK2427486T3 (en) 2009-05-07 2015-05-26 Novozymes Biopharma Dk As A process for purifying albumin
WO2010144468A1 (en) 2009-06-10 2010-12-16 Abbott Laboratories 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
EP2459308A1 (en) * 2009-07-28 2012-06-06 instrAction GmbH Specific sorbent for binding proteins and peptides, and separation method using the same
AU2010298720B2 (en) * 2009-09-23 2015-07-23 Albert Einstein College Of Medicine, Inc. Prostaglandin transporter inhibitors and uses thereof
JP6038774B2 (ja) * 2011-03-24 2016-12-07 株式会社カネカ タンパク性物質結合性低分子化合物
US9834518B2 (en) 2011-05-04 2017-12-05 Ariad Pharmaceuticals, Inc. Compounds for inhibiting cell proliferation in EGFR-driven cancers
US20150166591A1 (en) 2012-05-05 2015-06-18 Ariad Pharmaceuticals, Inc. Methods and compositions for raf kinase mediated diseases
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
GB2513405A (en) * 2013-04-26 2014-10-29 Adc Biotechnology Ltd Method of synthesising ADCs using affinity resins
CN104148018B (zh) * 2013-05-14 2018-04-20 上海亨臻实业有限公司 抗体亲和纯化材料及其用途
EP2918641A1 (en) 2014-03-13 2015-09-16 Basf Se Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures
GB201419184D0 (en) 2014-10-28 2014-12-10 Adc Biotechnology Ltd Method of synthesising biomolecule-effector/reporter-conjugates using affinity resins
GB201419185D0 (en) 2014-10-28 2014-12-10 Adc Biotechnology Ltd Method of synthesising ADCs using affinity resin
RU2627849C1 (ru) * 2016-07-22 2017-08-14 Игорь Анатольевич Мнушкин Способ разделения газового потока на отдельные компоненты или фракции
RU2626354C9 (ru) * 2016-07-25 2017-10-04 Игорь Анатольевич Мнушкин Способ разделения газового потока на отдельные компоненты или фракции
CN109354600B (zh) * 2018-11-29 2021-08-10 浙江海洋大学 一种牛磺酸修饰的新型阿拉斯加鳕鱼多功能肽的制备方法
CN113527284B (zh) * 2021-07-16 2024-08-06 东莞市顶盛环保科技有限公司 一种含双酯基均三嗪衍生物的环保多功能材料及其制备方法与应用
CN113563324B (zh) * 2021-07-22 2024-08-06 东莞市顶盛环保科技有限公司 一种含酯基均三嗪的绿色环保多功能材料及其制备方法与应用
CN118719009B (zh) * 2024-07-18 2025-02-14 山东微领生物有限公司 一种层析介质改性方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726019A1 (de) * 1987-08-05 1989-02-16 Boehringer Mannheim Gmbh Verfahren zur abtrennung und reinigung von t-pa

Similar Documents

Publication Publication Date Title
JP2000500228A5 (https=)
JP2000500445A5 (https=)
JPH11506647A5 (https=)
JP2000500033A5 (https=)
JP2000500440A5 (https=)
JPH11513713A5 (https=)
JP2000500327A5 (https=)
JP2000500145A5 (https=)
JP2000500406A5 (https=)
JP2000500361A5 (https=)
JP2000500115A5 (https=)
JPH11512442A5 (https=)
JP2000500322A5 (https=)
JP2000500258A5 (https=)
JP2000500342A5 (https=)
JP2000500112A5 (https=)
JPH11510142A5 (https=)
JP2000500051A5 (https=)
JP2000500397A5 (https=)
JP2000500407A5 (https=)
JP2000500019A5 (https=)
JP2000500125A5 (https=)
JP2000500044A5 (https=)
JP2000500346A5 (https=)
JP2000500257A5 (https=)